🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to collect additional safety and efficacy data...
Status
Completed
Location
Chris O'Brien Lifehouse Oncology
Start Date
2016-10-18
Trial ID
NCT03306394
Treatments Being Tested
This study is designed as an international, open-label, controlled two-arm,...
Status
Completed
Location
Mayo Clinic Hospital
Start Date
2020-11-25
Trial ID
NCT04737187
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of S 95005 in patient...
Status
Completed
Location
Russian Cancer Research Center n.a. NN Blokhin (RCRC), Clinical Pharmacology and Chemotherapy department
Start Date
2017-03-03
Trial ID
NCT03274882
Treatments Being Tested
The main purpose of this study is to evaluate the progression-free survival...
Status
Completed
Location
Chris O'Brien Lifehouse Oncology
Start Date
2016-04-29
Trial ID
NCT02743221
Treatments Being Tested
The main purpose of this study is to assess the safety and tolerability and...
Status
Completed
Location
Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie
Start Date
2016-05
Trial ID
NCT02848443
Treatments Being Tested
This study is a retrospective study to compare the efficacy and safety betw...
Status
Completed
Location
Hunan Cancer hospital
Start Date
2020-11-01
Trial ID
NCT05869097
Treatments Being Tested
The main purpose of this study is to demonstrate the superiority of S 95005...
Status
Active Not Recruiting
Location
Centro de Oncología e Investigación de Buenos Aires COIBA
Start Date
2019-03-21
Trial ID
NCT03869892
Fruquintinib with PD-1 inhibitors (FP) and TAS-102 with bevacizumab (TB) ar...
Status
Completed
Location
Hunan Cancer hospital
Start Date
2019-07-01
Trial ID
NCT06031376
Treatments Being Tested